Cargando…

Bioluminescence-based visualization of CD4 T cell dynamics using a T lineage-specific luciferase transgenic model(1)

BACKGROUND: Rapid clonal expansion of T cells occurs in response to antigenic challenges. The kinetics of the T cell response has previously been described using tissue-based studies performed at defined time points. Luciferase bioluminescence has recently been utilized for non-invasive analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chewning, Joseph H, Dugger, Kari J, Chaudhuri, Tandra R, Zinn, Kurt R, Weaver, Casey T
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736162/
https://www.ncbi.nlm.nih.gov/pubmed/19650922
http://dx.doi.org/10.1186/1471-2172-10-44
Descripción
Sumario:BACKGROUND: Rapid clonal expansion of T cells occurs in response to antigenic challenges. The kinetics of the T cell response has previously been described using tissue-based studies performed at defined time points. Luciferase bioluminescence has recently been utilized for non-invasive analysis of in vivo biologic processes in real-time. RESULTS: We have created a novel transgenic mouse model (T-Lux) using a human CD2 mini-gene to direct luciferase expression specifically to the T cell compartment. T-Lux T cells demonstrated normal homing patterns within the intact mouse and following adoptive transfer. Bioluminescent signal correlated with T cell numbers in the whole body images as well as within specific organ regions of interest. Following transfer into lymphopenic (RAG2(-/-)) recipients, homeostatic proliferation of T-Lux T cells was visualized using bioluminescent imaging. Real-time bioluminescent analysis of CD4(+ )T cell antigen-specific responses enabled real-time comparison of the kinetics and magnitude of clonal expansion and contraction in the inductive lymph node and tissue site of antigen injection. T cell expansion was dose-dependent despite the presence of supraphysiologic numbers of OVA-specific OT-II transgenic TCR T-Lux T cells. CD4(+ )T cells subsequently underwent a rapid (3–4 day) contraction phase in the draining lymph node, with a delayed contraction in the antigen delivery site, with bioluminescent signal diminished below initial levels, representing TCR clonal frequency control. CONCLUSION: The T-Lux mouse provides a novel, efficient model for tracking in vivo aspects of the CD4(+ )T cell response to antigen, providing an attractive approach for studies directed at immunotherapy or vaccine design.